Citius Oncology Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.03

-0.02 (-1.90%)

As of Sep 28, 10:23 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +3,001.0% upside

Low Target $22.24

Average Target $31.94

High Target $42.20

Current Price $1.03

Current
$1.03

Target
$31.94

$22.24 $31.94 avg $42.20

Scenario Analysis

Bear Case

$22.24

2,059.2%

Low target

Base Case

$31.94

+3,001.0%

Avg target

Bull Case

$42.20

+3,997.1%

High target

Risk/Reward

1.9x

Balanced

Price in Context

52-Week High

$2.25

-54.2% from high

52-Week Low

$0.49

+109.8% from low

Target vs 52W High

$31.94

+1,319.6% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-3.3%
AMGN Amgen Inc	Hold	43	47%	$190.87	-54.4%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+138.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-16.9%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-89.8%
MRNA Moderna Inc	Hold	30	37%	$149.45	-24.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-65.3%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-43.4%